{
    "2018-07-23": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Cramer Remix: Alphabet has broken this troubling trend after reporting earnings",
                "features": {
                    "keywords": [
                        "Alphabet",
                        "earnings",
                        "troubling trend",
                        "broken"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pullback in Abbott Labs Gives Buyers Another Chance",
                "features": {
                    "keywords": [
                        "Abbott Labs",
                        "pullback",
                        "buyers",
                        "chance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Agios (AGIO) Secures FDA Approval for Leukemia Drug Tibsovo",
                "features": {
                    "keywords": [
                        "Agios",
                        "FDA",
                        "approval",
                        "Leukemia",
                        "Tibsovo"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}